CRL's solid prospects in the DSA segment and strategic partnerships present a promising opportunity for investors.

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced that by introducing the DeepSeek model, they have successfully achieved a major ...

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...

Bill Gates discussed his teenage experimentation with drugs like LSD and cannabis alongside Steve Jobs. He eventually stopped ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...